136 related articles for article (PubMed ID: 36404401)
21. Coating-techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation.
Wendel HP; Ziemer G
Eur J Cardiothorac Surg; 1999 Sep; 16(3):342-50. PubMed ID: 10554855
[TBL] [Abstract][Full Text] [Related]
22. Device thrombosis and pre-clinical blood flow models for assessing antithrombogenic efficacy of drug-device combinations.
Sukavaneshvar S
Adv Drug Deliv Rev; 2017 Mar; 112():24-34. PubMed ID: 27496706
[TBL] [Abstract][Full Text] [Related]
23. A bioinspired omniphobic surface coating on medical devices prevents thrombosis and biofouling.
Leslie DC; Waterhouse A; Berthet JB; Valentin TM; Watters AL; Jain A; Kim P; Hatton BD; Nedder A; Donovan K; Super EH; Howell C; Johnson CP; Vu TL; Bolgen DE; Rifai S; Hansen AR; Aizenberg M; Super M; Aizenberg J; Ingber DE
Nat Biotechnol; 2014 Nov; 32(11):1134-40. PubMed ID: 25306244
[TBL] [Abstract][Full Text] [Related]
24. Hemocompatibility Comparison of Biomedical Grade Polymers Using Rabbit Thrombogenicity Model for Preparing Nonthrombogenic Nitric Oxide Releasing Surfaces.
Handa H; Major TC; Brisbois EJ; Amoako KA; Meyerhoff ME; Bartlett RH
J Mater Chem B; 2014 Feb; 2(8):1059-1067. PubMed ID: 24634777
[TBL] [Abstract][Full Text] [Related]
25. The hemocompatibility of a nitric oxide generating polymer that catalyzes S-nitrosothiol decomposition in an extracorporeal circulation model.
Major TC; Brant DO; Burney CP; Amoako KA; Annich GM; Meyerhoff ME; Handa H; Bartlett RH
Biomaterials; 2011 Sep; 32(26):5957-69. PubMed ID: 21696821
[TBL] [Abstract][Full Text] [Related]
26. Strategy for the hemocompatibility testing of microparticles.
Braune S; Basu S; Kratz K; Johansson JB; Reinthaler M; Lendlein A; Jung F
Clin Hemorheol Microcirc; 2016; 64(3):345-353. PubMed ID: 27886001
[TBL] [Abstract][Full Text] [Related]
27. Heparin-Free Extracorporeal Life Support Using Tethered Liquid Perfluorocarbon: A Feasibility and Efficacy Study.
Roberts TR; Harea GT; Singha P; Sieck KN; Beely BM; Wendorff DS; Choi JH; Ande S; Handa H; Batchinsky AI
ASAIO J; 2020 Jul; 66(7):809-817. PubMed ID: 31453831
[TBL] [Abstract][Full Text] [Related]
28. Mitigation of coagulation by removing clotting factors part 2: heparin-free extracorporeal circulation in a porcine model.
Sukavaneshvar S; Parker JT; Beutler DS; Burns G; Solen KA; Mohammad SF
ASAIO J; 2007; 53(4):421-7. PubMed ID: 17667225
[TBL] [Abstract][Full Text] [Related]
29. Reduced platelet activation and thrombosis in extracorporeal circuits coated with nitric oxide release polymers.
Annich GM; Meinhardt JP; Mowery KA; Ashton BA; Merz SI; Hirschl RB; Meyerhoff ME; Bartlett RH
Crit Care Med; 2000 Apr; 28(4):915-20. PubMed ID: 10809259
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of acute stent thrombosis under high-shear flow conditions by a nitric oxide donor, DMHD/NO. An ex vivo porcine arteriovenous shunt study.
Kaul S; Makkar RR; Nakamura M; Litvack FI; Shah PK; Forrester JS; Hutsell TC; Eigler NL
Circulation; 1996 Nov; 94(9):2228-34. PubMed ID: 8901676
[TBL] [Abstract][Full Text] [Related]
31.
Klein M; Tack JC; Mager I; Maas J; Schmitz-Rode T; Arens J; Steinseifer U; Clauser JC
Biomed Tech (Berl); 2022 Dec; 67(6):471-480. PubMed ID: 36041741
[No Abstract] [Full Text] [Related]
32. Platelet and leukocyte count assay for thrombogenicity screening of biomaterials and medical devices: Evaluation and improvement of ASTM F2888 test standard.
Lu Q; Nehrer JM; Li J; Jamiolkowski MA; Rinaldi JE; Malinauskas RA
J Biomed Mater Res B Appl Biomater; 2021 Dec; 109(12):2259-2267. PubMed ID: 34106517
[TBL] [Abstract][Full Text] [Related]
33. Nitric oxide gas infusion to the oxygenator enhances the biocompatibility of heparin coated extracorporeal bypass circuits.
Hayashi Y; Sawa Y; Nishimura M; Chang JC; Amemiya A; Kagisaki K; Taketani S; Yamaguchi T; Hirata N; Ohtake S; Matsuda H
ASAIO J; 1998; 44(5):M456-61. PubMed ID: 9804472
[TBL] [Abstract][Full Text] [Related]
34. Blood biocompatibility of surface-bound multi-walled carbon nanotubes.
Gaffney AM; Santos-Martinez MJ; Satti A; Major TC; Wynne KJ; Gun'ko YK; Annich GM; Elia G; Radomski MW
Nanomedicine; 2015 Jan; 11(1):39-46. PubMed ID: 25072378
[TBL] [Abstract][Full Text] [Related]
35. The effects of nitric oxide on coagulation during simulated extracorporeal membrane oxygenation.
Rauch ED; Stammers AH; Mejak BL; Vang SN; Viessman TW
J Extra Corpor Technol; 2000 Dec; 32(4):214-9. PubMed ID: 11194058
[TBL] [Abstract][Full Text] [Related]
36. Thromboresistance characterization of extruded nitric oxide-releasing silicone catheters.
Amoako KA; Archangeli C; Handa H; Major T; Meyerhoff ME; Annich GM; Bartlett RH
ASAIO J; 2012; 58(3):238-46. PubMed ID: 22395119
[TBL] [Abstract][Full Text] [Related]
37. Nonthrombogenic, adhesive cellular lining for left ventricular assist devices.
Scott-Burden T; Tock CL; Bosely JP; Clubb FJ; Parnis SM; Schwarz JJ; Engler DA; Frazier OH; Casscells SW
Circulation; 1998 Nov; 98(19 Suppl):II339-45. PubMed ID: 9852924
[TBL] [Abstract][Full Text] [Related]
38. Nitric oxide diffusion across membrane lungs protects platelets during simulated extracorporeal circulation.
Keh D; Gerlach M; Kürer I; Spielmann S; Kerner T; Busch T; Hansen R; Falke K; Gerlach H
Eur J Clin Invest; 1999 Apr; 29(4):344-50. PubMed ID: 10231347
[TBL] [Abstract][Full Text] [Related]
39. An ex vivo evaluation of blood coagulation and thromboresistance of two extracorporeal circuit coatings with reduced and full heparin dose.
Teligui L; Dalmayrac E; Mabilleau G; Macchi L; Godon A; Corbeau JJ; Denommé AS; Bouquet E; Boer C; Baufreton C
Interact Cardiovasc Thorac Surg; 2014 Jun; 18(6):763-9. PubMed ID: 24632424
[TBL] [Abstract][Full Text] [Related]
40. Nitric oxide releasing Tygon materials: studies in donor leaching and localized nitric oxide release at a polymer-buffer interface.
Joslin JM; Lantvit SM; Reynolds MM
ACS Appl Mater Interfaces; 2013 Oct; 5(19):9285-94. PubMed ID: 23957655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
